Emcure's win for Semaglutide with Novo Nordisk highlights a critical strategy for Indian pharma

Emcure's win for Semaglutide with Novo Nordisk highlights a critical strategy for Indian pharma. Securing a global innovator partnership after "fierce competition" isn't just a deal; it's a capability validation. It positions you for future MNC collaborations, signaling market access and quality. Build that trust.

https://pharma.economictimes.indiatimes.com/news/pharma-industry/nine-companies-were-eyeing-for-semaglutide-second-brand-pact-with-novo-emcure-md/127924535